Literature DB >> 33560164

Predicting severe toxicities with intensive induction chemotherapy for adult acute myeloid leukemia: analysis of SWOG Cancer Research Network trials S0106 and S1203.

Anna Moseley1, Megan Othus1, Guillermo Garcia-Manero2, Frederick R Appelbaum3,4, Harry P Erba5, Roland B Walter3,6,7,8.   

Abstract

Entities:  

Mesh：

Year:  2021        PMID： 33560164      PMCID： PMC8282671          DOI： 10.1080/10428194.2021.1881512

Source DB:  PubMed          Journal:  Leuk Lymphoma        ISSN： 1026-8022


× No keyword cloud information.
  9 in total

1.  The development and validation of two prediction models to identify employees at risk of high sickness absence.

Authors:  Corné A Roelen; Willem van Rhenen; Johan W Groothoff; Jac J van der Klink; Ute Bültmann; Martijn W Heymans
Journal:  Eur J Public Health       Date:  2012-04-25       Impact factor: 3.367

Review 2.  Diagnosis and management of AML in adults: 2017 ELN recommendations from an international expert panel.

Authors:  Hartmut Döhner; Elihu Estey; David Grimwade; Sergio Amadori; Frederick R Appelbaum; Thomas Büchner; Hervé Dombret; Benjamin L Ebert; Pierre Fenaux; Richard A Larson; Ross L Levine; Francesco Lo-Coco; Tomoki Naoe; Dietger Niederwieser; Gert J Ossenkoppele; Miguel Sanz; Jorge Sierra; Martin S Tallman; Hwei-Fang Tien; Andrew H Wei; Bob Löwenberg; Clara D Bloomfield
Journal:  Blood       Date:  2016-11-28       Impact factor: 22.113

Review 3.  Selection of initial therapy for newly-diagnosed adult acute myeloid leukemia: Limitations of predictive models.

Authors:  Roland B Walter; Elihu H Estey
Journal:  Blood Rev       Date:  2020-03-30       Impact factor: 8.250

4.  A phase 3 study of gemtuzumab ozogamicin during induction and postconsolidation therapy in younger patients with acute myeloid leukemia.

Authors:  Stephen H Petersdorf; Kenneth J Kopecky; Marilyn Slovak; Cheryl Willman; Thomas Nevill; Joseph Brandwein; Richard A Larson; Harry P Erba; Patrick J Stiff; Robert K Stuart; Roland B Walter; Martin S Tallman; Leif Stenke; Frederick R Appelbaum
Journal:  Blood       Date:  2013-04-16       Impact factor: 22.113

Review 5.  Management of older or unfit patients with acute myeloid leukemia.

Authors:  R B Walter; E H Estey
Journal:  Leukemia       Date:  2014-07-09       Impact factor: 11.528

6.  Quantitative analysis of the color change after iodine staining for diagnosing esophageal high-grade intraepithelial neoplasia and invasive cancer.

Authors:  Ryu Ishihara; Takuya Yamada; Hiroyasu Iishi; Motohiko Kato; Shunsuke Yamamoto; Sachiko Yamamoto; Eriko Masuda; Koichi Tatsumi; Yoji Takeuchi; Koji Higashino; Noriya Uedo; Masaharu Tatsuta; Shingo Ishiguro
Journal:  Gastrointest Endosc       Date:  2008-08-20       Impact factor: 9.427

7.  Can routine laboratory tests discriminate between severe acute respiratory syndrome and other causes of community-acquired pneumonia?

Authors:  Matthew P Muller; George Tomlinson; Thomas J Marrie; Patrick Tang; Allison McGeer; Donald E Low; Allan S Detsky; Wayne L Gold
Journal:  Clin Infect Dis       Date:  2005-03-16       Impact factor: 9.079

Review 8.  Therapeutic Choice in Older Patients with Acute Myeloid Leukemia: A Matter of Fitness.

Authors:  Raffaele Palmieri; Giovangiacinto Paterno; Eleonora De Bellis; Lisa Mercante; Elisa Buzzatti; Fabiana Esposito; Maria Ilaria Del Principe; Luca Maurillo; Francesco Buccisano; Adriano Venditti
Journal:  Cancers (Basel)       Date:  2020-01-02       Impact factor: 6.639

9.  Rapid Donor Identification Improves Survival in High-Risk First-Remission Patients With Acute Myeloid Leukemia.

Authors:  John M Pagel; Megan Othus; Guillermo Garcia-Manero; Min Fang; Jerald P Radich; David A Rizzieri; Guido Marcucci; Stephen A Strickland; Mark R Litzow; M Lynn Savoie; Stephen R Spellman; Dennis L Confer; Jeffrey W Chell; Maria Brown; Bruno C Medeiros; Mikkael A Sekeres; Tara L Lin; Geoffrey L Uy; Bayard L Powell; Ruthee-Lu Bayer; Richard A Larson; Richard M Stone; David Claxton; James Essell; Selina M Luger; Sanjay R Mohan; Anna Moseley; Harry P Erba; Frederick R Appelbaum
Journal:  JCO Oncol Pract       Date:  2020-01-27
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.